Rivaroxaban for the treatment of venous thromboembolism in pediatric patients.

Omri Cohen Sarina Levy-Mendelovich Walter Ageno

Published in: Expert review of cardiovascular therapy (2020)

Rivaroxaban represents an appealing therapeutic alternative for VTE in children. Further research should explore additional indications for rivaroxaban in the pediatric population beyond that of VTE.

Keyphrases

venous thromboembolism
direct oral anticoagulants
young adults
atrial fibrillation